Canagliflozin treatment in patients with type 2 diabetes mellitus

Nursing and Health Professions

• Canagliflozin 75%
• Clinical Pharmacist 50%
• Patient with Type 2 Diabetes 50%
• Sodium Glucose Cotransporter 2 Inhibitor 50%
• Hypoglycemia 50%
• Inpatient 50%
• Monotherapy 25%
• Practice Guideline 25%
• Systolic Blood Pressure 25%
• Body Weight 25%
• Glycosylated Hemoglobin 25%
• Electric Potential 25%
• Control 25%
• Patient 25%
• Patient with Diabetes 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Canagliflozin 75%
• Sodium Glucose Cotransporter 2 Inhibitor 50%
• Hypoglycemia 50%
• Monotherapy 25%
• Glycosylated Hemoglobin 25%